Comparison of Erector Spinae Plane Block and Caudal Block in Pediatric Patients Aged 1 to 8 Years Undergoing Lower Abdominal Surgery

May 6, 2026 updated by: Ankara City Hospital Bilkent

In routine pediatric surgical practice, lower abdominal surgeries are commonly performed. Inadequate control of postoperative pain can hinder functional recovery and may lead to negative behavioral changes as well as parental dissatisfaction. Regional anesthesia techniques are widely recommended for pain management in pediatric surgery, as they reduce the need for parenteral opioids and improve the effectiveness of postoperative pain control, patient comfort, and parental satisfaction.

Various nerve block techniques have been developed to enhance postoperative analgesia and facilitate recovery in pediatric patients. However, there is still no consensus regarding the most effective regional anesthesia strategy for pediatric surgical procedures.

Among regional anesthesia techniques used for pain management in children undergoing lower abdominal surgery, caudal block remains the most commonly applied method. The introduction of real-time ultrasound guidance has improved the reliability and safety of caudal blocks. Nevertheless, a major limitation of this technique is its relatively short duration of action following a single injection, even when long-acting local anesthetics or adjuvant agents are used. Consequently, several fascial plane blocks, such as the quadratus lumborum block, transversus abdominis plane block, and rectus sheath block, have been proposed as alternative approaches for postoperative analgesia in children.

The erector spinae plane block is a regional anesthesia technique that has been applied at thoracic, lumbar, cervical, and sacral levels for both acute and chronic pain management. By providing blockade of both somatic and visceral pain pathways, it has demonstrated effective postoperative analgesic properties in a variety of thoracic and abdominal surgical procedures. The technique involves the injection of a local anesthetic into the interfascial plane between the erector spinae muscle and the transverse process, allowing longitudinal spread of the anesthetic across multiple spinal levels.

With a growing body of evidence supporting its feasibility and effectiveness, the erector spinae plane block has gained increasing attention in pediatric anesthesia practice.

The aim of this study is to evaluate and compare the analgesic efficacy and safety of ultrasound-guided erector spinae plane block and caudal block in pediatric patients undergoing unilateral lower abdominal surgery under general anesthesia. The primary objective is to compare postoperative pain levels between the two techniques using the FLACC score, which assesses facial expression, leg position, activity, crying, and consolability. Secondary objectives include the evaluation of intraoperative heart rate, blood pressure, and oxygen saturation, block application times, parental satisfaction, and the incidence of postoperative side effects.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Children aged 1 to 8 years

Scheduled for elective lower abdominal surgery

American Society of Anesthesiologists (ASA) physical status I-II

Written informed consent obtained from parent(s) or legal guardian(s)

Exclusion Criteria:

Presence of anatomical abnormalities

Coagulation disorders

Infection at the site of block application

Severe cardiovascular, neurological, respiratory, or metabolic disease

Known allergy to study medications

Failed regional block

Bilateral surgery or additional surgical procedures involving different surgical sites

Refusal of parent(s) or legal guardian(s) to provide consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Caudal Block Group
Participants will receive an ultrasound-guided caudal epidural block with bupivacaine.
A single-shot ultrasound-guided caudal epidural block will be performed via the sacral hiatus using a standard technique.
Active Comparator: Erector spinae plane block group
Participants will receive an ultrasound-guided erector spinae plane block with bupivacaine.
A single-shot ultrasound-guided erector spinae plane block will be performed at the L1 transverse process level using an in-plane technique.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FLACC pain score
Time Frame: 0, 30 minutes; 1, 2, 4, 8, 12, and 24 hours after surgery
Postoperative pain will be assessed using the FLACC scale. Unit of Measure: Score (0-10)
0, 30 minutes; 1, 2, 4, 8, 12, and 24 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to first rescue analgesia
Time Frame: Up to 24 hours postoperatively
Time from the end of surgery to the first administration of rescue analgesic
Up to 24 hours postoperatively
Duration of Effective Analgesia
Time Frame: Up to 24 hours postoperatively
Time from block application to the first FLACC pain score ≥4
Up to 24 hours postoperatively
Duration of Anesthesia
Time Frame: Intraoperative period
Time from anesthesia induction to awake extubation
Intraoperative period
Duration of Surgery
Time Frame: Intraoperative period
Time from skin incision to skin closure
Intraoperative period
Block Performance Time
Time Frame: Intraoperative period
Time from needle insertion to completion of block procedure
Intraoperative period
Intraoperative Heart Rate
Time Frame: 0, 15, 30, 45 minutes and 1 hour after inductio
Heart rate measured intraoperatively
0, 15, 30, 45 minutes and 1 hour after inductio
Intraoperative Mean Arterial Pressure
Time Frame: 0, 15, 30, 45 minutes and 1 hour after induction
Mean arterial pressure measured intraoperatively
0, 15, 30, 45 minutes and 1 hour after induction
Intraoperative Oxygen Saturation
Time Frame: 0, 15, 30, 45 minutes and 1 hour after induction
Peripheral oxygen saturation measured intraoperatively
0, 15, 30, 45 minutes and 1 hour after induction
Postoperative Adverse Events
Time Frame: First 24 hours postoperatively
Incidence of postoperative adverse events including nausea, vomiting, nerve injury, or infection
First 24 hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zeki D Kuvet, Ankara City Hospital Bilkent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 15, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

February 16, 2026

First Posted (Actual)

February 23, 2026

Study Record Updates

Last Update Posted (Actual)

May 11, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

October 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Erector Spinae Plane Block

Clinical Trials on caudal block

Subscribe